G. Habib, P. Lancellotti, M. J. Antunes, M. G. Bongiorni, J. Casalta et al., , 2015.

, ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology. Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015.

, Groupe de Pathologie Infectieuse Pédiatrique (GPIP), Société Française d'Anesthésie et de Réanimation (SFAR), Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT)

;. Société-française-d'hygiène-hospitalière and . Sfhh), Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis), Med Mal Infect, vol.40, issue.4, pp.185-211, 2010.

D. A. Hammond, M. N. Smith, C. Li, S. M. Hayes, K. Lusardi et al., Systematic Review and Meta-Analysis of Acute Kidney Injury Associated with Concomitant Vancomycin and Piperacillin/tazobactam, Clin Infect Dis, vol.64, issue.5, pp.666-674, 2017.

M. Osmont, M. Cuggia, E. Polard, C. Riou, F. Balusson et al., Use of the PMSI for the detection of adverse drug reactions, Therapie, vol.68, issue.4, pp.285-95, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00937579

M. Verdier, O. Tribut, P. Tattevin, L. Tulzo, Y. Michelet et al., Simultaneous Determination of 12 beta-Lactam Antibiotics in Human Plasma by HighPerformance Liquid Chromatography with UV Detection: Application to Therapeutic Drug Monitoring, Antimicrob Agents Chemother, vol.55, issue.10, pp.4873-4882, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00875271

M. Neuville, N. El-helali, E. Magalhaes, A. Radjou, R. Smonig et al., Systematic overdosing of oxa-and cloxacillin in severe infections treated in ICU: risk factors and side effects, Ann Intensive Care, vol.7, issue.1, p.34, 2017.

. Kdigo-aki-work and . Group, KDIGO clinical practice guideline for acute kidney injury, Kidney Int Suppl, vol.2, pp.19-36, 2012.

P. C. Grimm, M. R. Ogborn, A. J. Larson, and J. F. Crocker, Interstitial nephritis induced by cloxacillin, Nephron, vol.51, issue.2, pp.285-291, 1989.

R. García-ortiz, R. S. Espinoza, G. R. Silva, R. K. Alonso, H. S. Opazo et al.,

, Cloxacillin-induced acute tubulo interstitial nephritis, Ann Pharmacother, vol.26, pp.1241-1243, 1992.

Z. Billip-tomecka, D. W?odarczyk, R. Gellert, K. Wardyn, and K. Ostrowski,

, Pol Tyg Lek, vol.47, pp.1113-1117, 1992.

E. Bruckheimer and A. Abrahamov, Cloxacillin-induced interstitial nephritis, Isr J Med Sci, vol.27, pp.159-60, 1991.

H. Khalili, S. Bairami, and M. Kargar, Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome, Acta Med Iran, vol.51, pp.871-879, 2013.

P. Loubet, C. Burdet, W. Vindrios, N. Grall, M. Wolff et al., Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a narrative review, Clin Microbiol Infect, vol.2017, issue.17, pp.30358-30358

L. Labriola, M. Jadoul, M. Daudons, Y. Pirson, and M. Lambert, Massive amoxicillin crystalluria causing anuric acute renal failure, Clin Nephrol, vol.59, pp.455-462, 2003.
DOI : 10.5414/cnp59455

S. G. Yarlagadda and M. A. Perazella, Drug-induced crystal nephropathy: an update, Expert Opin Drug Saf, vol.7, pp.147-58, 2008.
DOI : 10.1517/14740338.7.2.147

V. Zeller, D. Puyraimond-zemmour, T. Sené, O. Lidove, V. Meyssonnier et al., Amoxicillin crystalluria, an emerging complication with an old and well-known antibiotic, Antimicrob Agents Chemother, vol.60, p.3248, 2016.
DOI : 10.1128/aac.00359-16
URL : https://aac.asm.org/content/60/5/3248.full.pdf

R. Sutherland, E. Croydon, and G. N. Rolinson, Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin, Br Med J, vol.4, pp.455-60, 1970.
DOI : 10.1136/bmj.4.5733.455
URL : https://www.bmj.com/content/4/5733/455.full.pdf

S. R. Challagundla, D. Knox, A. Hawkins, D. Hamilton, W. Flynn et al., Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement, Nephrol Dial Transplant, vol.28, pp.612-621, 2013.

M. Barza and L. Weinstein, Pharmacokinetics of the penicillins in man, Clin Pharmacokinet, vol.1, pp.297-308, 1976.

G. Brillet, A. P. Schmidt, A. Catella, L. Julien, L. Bénard et al., Hospital costs of contrastinduced nephropathy, Value Health, vol.18, p.510, 2015.

W. Picard, F. Bazin, B. Clouzeau, H. Bui, M. Soulat et al., Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock, Antimicrob Agents Chemother, vol.58, pp.7468-74, 2014.

. A-c-c-e-p-t-e-d-m-a-n-u-s-c-r-i-p-t-20,

M. Cobussen, J. De-kort, R. M. Dennert, S. H. Lowe, and P. M. Stassen, No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis, Infect Dis (Lond), vol.48, pp.274-280, 2016.

G. N. Rolinson and R. Sutherland, The binding of antibiotics to serum proteins, Br J Pharmacol Chemother, vol.25, issue.3, pp.638-50, 1965.

W. E. Lindup and M. C. Orme, Clinical pharmacology: plasma protein binding of drugs, Br Med J (Clin Res Ed), vol.282, pp.212-216, 1981.

J. W. Bins and H. Mattie, Saturation of the tubular excretion of beta-lactam antibiotics, Br J Clin Pharmacol, vol.25, pp.41-50, 1988.

L. G. Visser, P. Arnouts, R. Van-furth, M. H. Van-den-broek, and P. J. , Clinical pharmacokinetics of continuous intravenous administration of penicillins, Clin Infect Dis, vol.17, pp.491-496, 1993.
DOI : 10.1093/clinids/17.3.491

A. Charmillon, E. Novy, N. Agrinier, M. Leone, A. Kimmoun et al., The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for ?-lactam administration and therapeutic drug monitoring among critically ill patients in France
URL : https://hal.archives-ouvertes.fr/hal-01466892

, Clin Microbiol Infect, vol.22, pp.625-656, 2016.

P. Tattevin, O. Tribut, C. Arvieux, M. Dupont, R. Flicoteaux et al., Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis, Clin Microbiol Infect, vol.11, p.20, 2005.

, Median eGFR mL/min, vol.52, pp.40-63